AI Insight
Researchers have discovered a potential tipping point in Alzheimer's disease progression that determines whether brain changes result in dementia. The critical factor appears to be the manner in which the brain's immune cells respond to the accumulation of amyloid plaques and tau proteins. This finding suggests that the immune response, rather than simply the presence of pathological proteins, may be decisive in preserving or losing cognitive function.
Why it matters
This discovery could redirect therapeutic approaches from merely targeting plaques and tau to modulating immune cell responses, potentially helping maintain cognitive resilience even when brain pathology is present. It may explain why some individuals with Alzheimer's-related brain changes remain cognitively normal while others develop dementia.
Understand the Science
Scientists have identified a possible tipping point that helps determine whether Alzheimer’s-related brain changes lead to dementia. The key may lie in how the brain’s immune cells respond to plaques and tau, offering a promising new target for treatments designed to extend cognitive resilience.
Source: A hidden Alzheimer’s tipping point may decide who gets dementia